Sunday

4th Jun 2023

EU defends all vaccines, amid lower AstraZeneca take-up

  • Several countries, including Germany, Belgium, and France, have advised against giving AstraZeneca vaccine to the elderly (Photo: European Commission)

The European Commission defended the bloc's strict regulatory process for vaccines as crucial for both safety as well as for persuading EU citizens to get the jab, calling on member states to fight any particular vaccine hesitancy with more information.

The comments come after several member states reported a low acceptance rate for the AstraZeneca vaccine, with healthcare workers opting for other jabs - triggering fears over a knock-on potential slowdown of national vaccine programmes.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

"[EMA's] assessment is itself a very powerful signal to citizens that these vaccines that they are injected with are safe and effective," a commission spokesperson said on Monday (22 February).

"But, in addition, it is important that member states and the commission continue to inform citizens of the importance of getting the vaccines done because we need certain levels of vaccination to win this fight against the virus," he added.

Brussels aims to vaccinate at least 70 percent of its adult population by the end of September.

However, health authorities in some European countries - such as Germany, Italy, Austria and Bulgaria - are facing resistance to AstraZeneca's vaccine over fears and confusion regarding age limitations, efficacy against new mutations and side effects.

Several countries, including Germany, Belgium, and France, have advised against giving it to the elderly.

And health workers in some members states have reported stronger reactions from the AstraZeneca jab than those seen with the alternative vaccines from Moderna and Pfizer/BioNTech.

For example, two of 21 healthcare regions in Sweden had to pause vaccinations of their staff when a quarter called in sick after being vaccinated with the AstraZeneca shot.

In Germany, meanwhile, only some 187,000 of the 1.5 million AstraZeneca vaccine doses received so far have been used, according to the Robert Koch Institute.

And experts warned that the country's vaccine schedule could be pushed back by up to two months if the AstraZeneca jab is not widely accepted.

"From our point of view, it is wrong that this vaccine is available but not being used," said last week German health minister Jens Spahn.

Earlier this month, a group representing 3,000 doctors in Italy also wrote in a letter to the Italian government that "private doctors and dentists be inoculated with mRNA vaccines" like those developed by Moderna and Pfizer/BioNTech, arguing that "there is evidence they are more effective" in comparison to AstraZeneca.

AstraZeneca's vector-based vaccine is the third jab authorised in the EU. It demonstrated around a 60 percent efficacy in the clinical trials, while Moderna and Pfizer/BioNtech jabs showed a 95 percent.

Hospitalisations fall

Meanwhile, a research led by Public Health Scotland found on Monday that hospitalisations were reduced by 85 percent and 94 percent of the Pfizer/BioNtech and AstraZeneca jabs respectively in the fourth week after the first dose.

For people over 80 years old, there was an overall 81 percent cut in hospital admissions.

The data, covering 1.14 million vaccinations given in Scotland between 8 December and 15 February, validates the UK's decision to delay the second jab for up to twelve weeks in favour of vaccinating as many people as possible with a single dose.

Lead researcher professor Aziz Sheikh said the results showed that vaccines were working "spectacularly".

"These results are very encouraging and have given us great reasons to be optimistic for the future," she said.

Agenda

EU summit on vaccine problems This WEEK

EU foreign affairs ministers will meet in Brussels and are expected to agree to visa-bans and asset-freezes on Russian officials involved in the jailing of opposition figurehead Alexei Navalny.

EU Commission casts doubt on Russian Sputnik vaccine

Hungary is buying up vaccines from Russia and China. But tricky regulatory oversight questions remain as the European Commission sheds doubt on the quality and safety of Sputnik production.

Stakeholder

I love the EU - but the vaccine strategy is a fiasco

In my opinion, the contracts Europe negotiated with the pharmaceutical companies were extremely unbalanced. Precise on pricing and liabilities but weak and vague on supply and timing, and with escape routes to the contractual obligations of the pharmaceutical companies involved.

Opinion

What Estonia and Slovakia did to beat AstraZeneca 'hesitancy'

Slovakia has launched a mass vaccination programme aimed at teachers and childcare workers. Estonia, for its part, has begun inoculating frontline workers including teachers, police officers and members of the armed forces ahead of schedule.

Column

What a Spanish novelist can teach us about communality

In a world where cultural clashes and sectarianism seems to be on the increase, Spanish novelist Javier Cercas (b.1962) takes the opposite approach. He cherishes both life in the big city and in the countryside.

Latest News

  1. Spanish PM to delay EU presidency speech due to snap election
  2. EU data protection chief launches Frontex investigation
  3. Madrid steps up bid to host EU anti-money laundering hub
  4. How EU leaders should deal with Chinese government repression
  5. MEPs pile on pressure for EU to delay Hungary's presidency
  6. IEA: World 'comfortably' on track for renewables target
  7. Europe's TV union wooing Lavrov for splashy interview
  8. ECB: eurozone home prices could see 'disorderly' fall

Stakeholders' Highlights

  1. International Sustainable Finance CentreJoin CEE Sustainable Finance Summit, 15 – 19 May 2023, high-level event for finance & business
  2. ICLEISeven actionable measures to make food procurement in Europe more sustainable
  3. World BankWorld Bank Report Highlights Role of Human Development for a Successful Green Transition in Europe
  4. Nordic Council of MinistersNordic summit to step up the fight against food loss and waste
  5. Nordic Council of MinistersThink-tank: Strengthen co-operation around tech giants’ influence in the Nordics
  6. EFBWWEFBWW calls for the EC to stop exploitation in subcontracting chains

Stakeholders' Highlights

  1. InformaConnecting Expert Industry-Leaders, Top Suppliers, and Inquiring Buyers all in one space - visit Battery Show Europe.
  2. EFBWWEFBWW and FIEC do not agree to any exemptions to mandatory prior notifications in construction
  3. Nordic Council of MinistersNordic and Baltic ways to prevent gender-based violence
  4. Nordic Council of MinistersCSW67: Economic gender equality now! Nordic ways to close the pension gap
  5. Nordic Council of MinistersCSW67: Pushing back the push-back - Nordic solutions to online gender-based violence
  6. Nordic Council of MinistersCSW67: The Nordics are ready to push for gender equality

Join EUobserver

Support quality EU news

Join us